Physician profile
Robert Bond Nolan
NPI 1871597781
$8,726.41
in general payments reported to CMS, 2019-2025
36 companies · $1,088 in 2025
The $1,088 reported for 2025 was more than what 87% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $491 · 2020: $1,071 · 2021: $1,543 · 2022: $1,822 · 2023: $1,573 · 2024: $1,137 · 2025: $1,088.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,799.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,798.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,901.74 | 2019-2025 | |
| Novo Nordisk INC | $1,227.53 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,040.53 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $798.97 | 2019-2024 | Repatha, Otezla |
| Glaxosmithkline, LLC. | $777.73 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $479.31 | 2020-2025 | |
| Lilly USA, LLC | $404.43 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Exact Sciences Corporation | $309.58 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Allergan, INC. | $212.61 | 2019-2021 | |
| Eisai INC. | $158.13 | 2020-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $145.88 | 2024-2025 | Caplyta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $136.93 | 2019-2023 | Jardiance |
| Esperion Therapeutics, INC. | $129.50 | 2020-2025 | Nexletol |
| Takeda Pharmaceuticals U.S.A., INC. | $111.10 | 2020-2023 | Trintellix |
| Biohaven Pharmaceutical Holding Company LTD. | $97.84 | 2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $96.31 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $84.03 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $83.73 | 2022-2023 | |
| Kowa Pharmaceuticals America, INC. | $58.96 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $56.10 | 2020-2021 | |
| Abbott Laboratories | $54.37 | 2022-2023 | Freestyle Libre |
| Janssen Pharmaceuticals, INC | $51.20 | 2019-2021 | |
| Amarin Pharma, INC. | $35.38 | 2021 | |
| Dexcom, INC. | $34.25 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $32.06 | 2023-2024 | Quviviq |
| Astellas Pharma US INC | $30.82 | 2021-2024 | Veozah |
| Boston Scientific Corporation | $25.82 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $23.49 | 2019-2020 | |
| Phathom Pharmaceuticals, INC. | $21.19 | 2025 | Voquezna |
| Philips North America LLC | $20.70 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| E.R. Squibb & Sons, L.L.C. | $18.89 | 2022 | |
| Radius Health, INC. | $15.28 | 2024 | Tymlos |
| Circassia INC. | $14.58 | 2019 | |
| Shield Therapeutics INC | $13.69 | 2025 | |
| Ibsa Pharma INC. | $12.69 | 2020 | |
| Horizon Therapeutics Plc | $11.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Nolan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.